237 related articles for article (PubMed ID: 2047945)
1. A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemia.
Steyn K; Weich HF; Vermaak WJ; Marais AD; Omar MA; Van Gelder AL; Fourie J; Kotze TJ; Stander I; Firth JC
S Afr Med J; 1991 Jun; 79(11):639-45. PubMed ID: 2047945
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia.
Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J
S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688
[TBL] [Abstract][Full Text] [Related]
3. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
Wenke K; Thiery J; Meiser B; Arndtz N; Seidel D; Reichart B
Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
[TBL] [Abstract][Full Text] [Related]
7. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
8. [Effects of simvastatin on atherogenic blood lipid pattern].
Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
[TBL] [Abstract][Full Text] [Related]
11. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
[TBL] [Abstract][Full Text] [Related]
12. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
Simons LA
Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Mol MJ; Stuyt PM; Stalenhoef AF
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
18. A one-year multicentre study of simvastatin in the treatment of hypercholesterolaemia. UK and Eire Simvastatin Study Group.
Br J Clin Pract; 1994; 48(5):231-5. PubMed ID: 7917813
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients.
Lansberg PJ; Mitchel YB; Shapiro D; Kastelein JJ; Altman R; Jerums G; Bolzano K; Giannini S; Davignon J; DeWailly P
Atherosclerosis; 1995 Aug; 116(2):153-62. PubMed ID: 7575771
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
Hsu I; Spinler SA; Johnson NE
Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
